Home >  News >  August, 2014

Drug Mix-Up Blinds Patient, Spurs Malpractice Verdict

Cataract patient given methylene blue instead of VisionBlue.

Published: August 22, 2014

A mix-up over sound-alike drugs is at the heart of a $1.5 million jury award earlier this week stemming from a botched cataract procedure that left a patient blind in one eye.

You might say the cataract team at North Carolina Specialty Hospital blue it. Ophthalmologist Timothy Young, MD, PhD, who at the time was practicing with co-defendant North Carolina Eye, Ear, Nose and Throat, in Durham, called for the ophthalmic dye VisionBlue during a cataract removal in 2008, according to news reports. But a nurse instead retrieved methylene blue, a compound sometimes used in endoscopic polypectomies and one that's toxic to eyes.

Both the nurse and a surgical technician testified that they announced what the drug was before it was given to Dr. Young, but he testified that he didn't hear them.

A second procedure to repair the severe damage caused by the mix-up failed, as did a full corneal transplant.

Calls for comment by Outpatient Surgery Magazine to Dr. Young, who now practices in Texas, and to North Carolina Eye, Ear, Nose and Throat, were not returned.

Jim Burger


Also in the News...

Misleading Latex Labeling May Contribute to Allergic Reactions
New Orleans Surgeon Avoids Video Voyeurism Charges
Compounding Pharmacy Owner Barry Cadden Acquitted of Murder
Study Finds Mobile App Follow-ups as Effective as In-Person Visits
Another Patient Death Raises Question: Is Gluteal Fat Grafting Safe?
Bill Would Eliminate Medicare Co-Pays for Polyp Removal During Colonoscopies
Former Head of Sales Testifies NECC President Knew His Company Was to Blame for Tainted Steroids Outbreak

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Texas Docs Court CMS for OK to Expand

Population needs dictate which physician-owned hospitals can build on.

News & Notes

News & Notes